A better way to detect and assess prostate cancer

The American Urological Association now recommends prostate MRI for patients at elevated risk before undergoing a biopsy.

A new tool has emerged to provide better detection and assessment of suspected prostate cancer. Known as prostate MRI (or multiparametric MRI), this test can help you and your doctor better understand your risk as well as help contribute to a more targeted and effective treatment of the disease.

OnQ Prostate

Through our partnership with CorTechs.ai prostate MRI at IHS uses a unique diffusion technique called OnQ Prostate along with artificial intelligence. OnQ Prostate is a post-processing software for multiparametric prostate MRI (mpMRI) images. It leverages an advanced diffusion MRI technique and utilizes artificial intelligence to enable greater accuracy in differentiating prostate cancer from normal prostate tissue. This provides valuable information that helps our doctors to differentiate between clinically significant, aggressive cancer and less threatening, slower-growing cancer. We are the only regional imaging center network to offer this advanced technology on all prostate MRI exams.

Improved Detection

This technology improves prostate cancer detection over mpMRI alone, giving you and your doctor an added measure of confidence in your prostate diagnosis. In fact, when mpMRI is combined with OnQ Prostate, it achieves 85% accuracy versus 79% accuracy with mpMRI alone.

OnQ Prostate: Case Study

OnQ Prostate Case Study

To understand why OnQ Prostate with RSI technology can make a real difference when it comes to your prostate MRI exam, please read the resources below. You can also download and share these PDFs with others, including your doctor.

The advantages of prostate MRI

MRI allows doctors to better visualize the entire prostate gland. This can help to rule out the need for a biopsy, or if one is needed, it can ensure that biopsies are taken from the most suspicious areas—and not just randomly.

At IHS, our advanced MRI systems provide exceptionally detailed images of soft tissue within the body, such as those of the prostate gland. Combined with our expertise in interpreting prostate MRI exams, this test can help detect or rule out suspected cancer, determine cancer stage, conclude whether the cancer is contained, and help you and your doctor determine an appropriate course of treatment. We can also detect other, non-cancerous diseases of the prostate, such as prostatitis (infection) or BPH (enlargement).

Prostate MRI is safe, accurate and painless, and has been shown to identify cancer in more than 50% of men whose initial biopsy was negative. 

Is prostate MRI right for me?

Prostate MRI is recommended if you have:
  • Elevated PSA and another risk factor for prostate cancer 
  • Experienced repeated, negative biopsies 
  • Already been diagnosed with prostate cancer, in particular small-volume, higher Gleason grade disease

If you are at risk for prostate cancer, prostate MRI may provide the “missing piece” of information needed to catch aggressive cancers early and avoid unnecessary treatment of cancers that pose little to no risk to your health.

Supporting Clinical Evidence

    1. Ahmed HU, Kirkham A, Arya M, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 2009; 6:197–206
    2. C J Harvey, MRCP, FRCR,1 J Pilcher, MRCP, FRCR,2 J Richenberg, MRCP, FRCR,3 U Patel, MRCP, FRCR,2 and F Frauscher, MD4 Applications of transrectal ultrasound in prostate cancer Br J Radiol. 2012 Nov; 85(Spec Iss 1): S3–S17.
Menu